-
- Top Message
- Corporate Philosophy・Long-term Vision・Medium-term Business Plan
- Value Creation Process
- History of Kyorin Group
- Our Business
- New Drugs: Drug Discovery and Development
- New Drugs: In-Licensing
- New Drugs: Marketing
- Infectious related products
- Over-the-Counter drugs
- Generic drugs
- Manufacturing
- Reliability Assurance
- Company Information
- Corporate Governance
- Corporate Brand
-
- Medium-term Business Plan “Vision 110 -Stage 1-”
- Long-term vision “Vision 110”
- Outline of Vison 110 -Stage 1-
- Strategy of Vision 110 -Stage 1-
- Performance targets in Vision 110 -Stage 1-
- Financial and Performance results
- Financial Highlights
- Key financial indicators
- Sales by business segments/mainly products
- Cash Flow
- Expenses of R&D / capital investment / depreciation
- Financial Data Download
- IR Library
- Shareholder Information
- IR Calendar
- Stock Quote(Open New window.)
- FAQ
- Business Risk
- Disclosure Policy
- Disclaimer